Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Anavex Life Sciences Corp AVXL

Healthcare Biotechnology
Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

Recent & Breaking News (NDAQ:AVXL)

SHAREHOLDER ALERT: Anavex Life Sciences Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Newsfile March 28, 2024

AVXL LAWSUIT ALERT: Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire March 28, 2024

Shareholders That Lost Money On Anavex Life Sciences Corporation(AVXL) Should Contact Levi & Korsinsky About Pending Class Action - AVXL

Accesswire March 28, 2024

IMPORTANT DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Accesswire March 28, 2024

Shareholders that lost money on Anavex Life Sciences Corporation (AVXL) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Accesswire March 28, 2024

AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit

Accesswire March 28, 2024

Contact Levi & Korsinsky by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation (AVXL)

Accesswire March 28, 2024

Levi & Korsinsky Notifies Shareholders of Anavex Life Sciences Corporation (AVXL) of a Class Action Lawsuit and an Upcoming Deadline

Accesswire March 28, 2024

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Anavex

Newsfile March 27, 2024

Lost Money on Anavex Life Sciences Corporation (AVXL)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Accesswire March 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Anavex Life Sciences Corp. - AVXL

PR Newswire March 27, 2024

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Newsfile March 27, 2024

Investors Who Lost Money On Anavex Life Sciences Corporation(AVXL) Should Contact Levi & Korsinsky About Pending Class Action - AVXL

Accesswire March 27, 2024

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Anavex Life Sciences Corp. (AVXL)

Business Wire March 27, 2024

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire March 27, 2024

Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact Levi & Korsinsky

Accesswire March 27, 2024

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of $100,000 to Contact the Firm

Accesswire March 27, 2024

Contact Levi & Korsinsky by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)

PR Newswire March 27, 2024

Levi & Korsinsky Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline - AVXL

Accesswire March 27, 2024

AVXL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Anavex Life Sciences Corp. Investors Can Join the Class Action Lawsuit

Accesswire March 27, 2024